Feltl Cuts MEDTOX (MTOX) to Hold Following Bid from Lab Corp.

Article Stock Quotes (2) Comments (0)

Feltl & Co downgraded MEDTOX Scientific (NASDAQ: MTOX) from Buy to Hold Monday morning following news of a $241 million deal with Lab Corp. (NYSE: LH). The firm's price target was raised from $21.50 to $27.

MDETOX shares are up about 35 percent at last check.

For an analyst ratings summary and ratings history on MEDTOX Scientific click here. For more ratings news on MEDTOX Scientific click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Bernstein Cuts BlackBerry (BBRY) to Underperform; Notes Weak BB10 Traction
• Wells Fargo Cuts Comerica (CMA) and First Horizon National (FHN) to Underperform
• Goldman Sachs Removes Williams Companies (WMB) from CL Buy List; Downgrades Williams Partners (WPZ) to Neutral

Create E-mail Alert Related Categories

Downgrades

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?